The interrelationship of bone and cardiovascular remodeling biomarkers and clinical peculiarities of coronary artery disease in postmenopausal women

Código QR

The interrelationship of bone and cardiovascular remodeling biomarkers and clinical peculiarities of coronary artery disease in postmenopausal women

Guardado en:

Detalles Bibliográficos
Autores principales:	Natalia Serhiivna Mykhailovska, Iryna Olehivna Stetsiuk, Tamila Olehivna Kulynych, Svitlana Vasylivna Gorbachova, Igor Valentynovych Zhulkevych
Formato:	article
Lenguaje:	EN
Publicado:	Termedia Publishing House 2020
Materias:	coronary artery disease postmenopausal osteoporosis serum biomarkers prognostic factors. Medicine R
Acceso en línea:	https://doaj.org/article/146e2efbb0b54447b0f8d60d288399c6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
por: Paula Rackoff
Publicado: (2009)

The predictive role of monocyte-lymphocyte ratio and plateletlymphocyte ratio in postmenopausal osteoporosis
por: Ibrahim Kale
Publicado: (2021)

The perioperative enhancing factors that might help the postmenopausal women tolerate the spinal implants
por: Akram Awadalla, et al.
Publicado: (2014)

The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil
por: Baccaro LF, et al.
Publicado: (2015)

Comparison of OSTA, FRAX and BMI for Predicting Postmenopausal Osteoporosis in a Han Population in Beijing: A Cross Sectional Study
por: Fan Z, et al.
Publicado: (2020)

Los riesgos de no usar terapia hormonal de la menopausia: deterioro de la calidad de vida
por: Blümel,Juan Enrique, et al.
Publicado: (2017)

Integrative Bone Metabolomics—Lipidomics Strategy for Pathological Mechanism of Postmenopausal Osteoporosis Mouse Model
por: Hongxia Zhao, et al.
Publicado: (2018)

LncRNA CASC11 is upregulated in postmenopausal osteoporosis and is correlated with TNF-α
por: Yu H, et al.
Publicado: (2019)

Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis
por: Liu Z, et al.
Publicado: (2020)

Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene
por: Luigi Gennari, et al.
Publicado: (2010)

Polimorfismos del gen del receptor de vitamina D y riesgo de fractura de cadera en la mujer adulta mayor de la Región del Bío Bío
por: Quevedo L,Iván, et al.
Publicado: (2008)

Alta prevalencia de osteoporosis en mujeres mapuches postmenopáusicas asintomáticas
por: Ponce L,Lucía, et al.
Publicado: (2002)

Impacto de los factores de riesgo coronario en mujeres de edad media
por: Blümel M,Juan E, et al.
Publicado: (2001)

Prevalence and Risk Factors of Osteoporosis in Chinese Postmenopausal Women Awaiting Total Knee Arthroplasty
por: Tao Y, et al.
Publicado: (2021)

Teriparatide in East Asian Postmenopausal Women with Osteoporosis in a Real-World Setting: A Baseline Analysis of the Asia and Latin America Fracture Observational Study (ALAFOS)
por: Chen CH, et al.
Publicado: (2020)

Teriparatide in East Asian Postmenopausal Women with Osteoporosis in a Real-World Setting: A Baseline Analysis of the Asia and Latin America Fracture Observational Study (ALAFOS) [Corrigendum]
por: Chen CH, et al.
Publicado: (2020)

Serum interleukin-17 and estradiol levels in postmenopausal women in relation to osteoporosis
por: Reem El-Mallah, et al.
Publicado: (2021)

Associations of polymorphisms in the gene promoters of cytokines and matrix metalloproteinases with bone mineral density in postmenopausal type 2 diabetic women
por: Olga N. Fazullina, et al.
Publicado: (2018)

Early Changes of VEGF Levels After Zoledronic Acid in Women With Postmenopausal Osteoporosis: A Potential Role of Vitamin D
por: Federica Bellone, et al.
Publicado: (2021)

Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial
por: Jiang Y, et al.
Publicado: (2014)

Enfermedad coronaria en mujeres pre y postmenopáusicas y su relación con la diabetes mellitus tipo 2
por: Gajardo-Navarrete,Jorge, et al.
Publicado: (2020)

Recomendaciones para el uso correcto de densitometría ósea en la práctica clínica. Consenso de la Sociedad Chilena de Endocrinología y Diabetes
por: Barberán M.,Marcela, et al.
Publicado: (2018)

Anabolic Bone Stimulus Requires a Pre-Exercise Meal and 45-Minute Walking Impulse of Suprathreshold Speed-Enhanced Momentum to Prevent or Mitigate Postmenopausal Osteoporosis within Circadian Constraints
por: Qingyun Zheng, et al.
Publicado: (2021)

Fracturas vertebrales, osteoporosis y vitamina D en la posmenopausia: Estudio en 555 mujeres en Chile
por: Rodríguez P,José A, et al.
Publicado: (2007)

Hyperprolactinemia in the postmenopause: versions and contraversions
por: Olga Ya. Leshchenko
Publicado: (2021)

Regulatory SNP of RREB1 is Associated With Bone Mineral Density in Chinese Postmenopausal Osteoporosis Patients
por: Shuo Feng, et al.
Publicado: (2021)

The relationships between bone turnover markers and bone mineral density in postmenopausal type 2 diabetic women
por: Vadim V. Klimontov, et al.
Publicado: (2016)

MicroRNA-151a-3p Functions in the Regulation of Osteoclast Differentiation: Significance to Postmenopausal Osteoporosis
por: He Y, et al.
Publicado: (2021)

Effects of short-term Nordic walking training on sarcopenia-related parameters in women with low bone mass: a preliminary study
por: Ossowski ZM, et al.
Publicado: (2016)

No Association between Metabolic Syndrome and Periodontitis in Korean Postmenopausal Women
por: Jeong-In Kim, et al.
Publicado: (2021)

The effectiveness of a basic exercise intervention to improve strength and balance in women with osteoporosis
por: Otero M, et al.
Publicado: (2017)

The Comparison of serum glutathione level between Hypertensive and Normotensive Postmenopausal Women
por: Mohammad Zarei, et al.
Publicado: (2017)

Soluble urokinase plasminogen activator receptor in one-year prediction of major adverse cardiac events in patients after first myocardial infarction treated with primary percutaneous coronary intervention
por: Rafał N. Wlazeł, et al.
Publicado: (2018)

Uterine leiomyoma with spontaneous intraleiomyoma hemorrhage, perforation, and hemoperitoneum in postmenopausal woman: Computed tomography diagnosis
por: Sultan R Alharbi
Publicado: (2013)

The effect of dietary and/or cosmetic argan oil on postmenopausal skin elasticity
por: Qiraouani Boucetta K, et al.
Publicado: (2015)

Association Between Bone Mineral Density and Lipid Profile in Chinese Women
por: Zhang Q, et al.
Publicado: (2020)

POSTMENOPAUSAL BLEEDING - A STRONG INDICATOR OF ENDOMETRIAL CARCINOMA
por: Saima Jadoon, et al.
Publicado: (2019)

Menopausal Symptoms among Postmenopausal Women of a Selected Municipality: A Cross-sectional Survey
por: Sitasma Sharma, et al.
Publicado: (2021)

Sixteen weeks of resistance training can decrease the risk of metabolic syndrome in healthy postmenopausal women
por: Conceição MS, et al.
Publicado: (2013)

Comparative safety and efficacy of tibolone and escitalopram in postmenopausal women
por: Rajnish Raj, et al.
Publicado: (2021)